Physician

Anna-Bianca Stashak, D.O.

According to 2025 Medicare claims, Anna-Bianca Stashak, D.O. (NPI: 1740692326) practices dermatology in the Johnson City, TN market, with the plurality of this provider's patient population coming from Washington, TN. This provider's primary affiliated billing organization is TRICITIES SKIN AND CANCER (NPI: 1295824415; TIN: 621822644) and primary practice location at 37604-3693.

Stashak's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 377 traditional Medicare patients, billed 7,384 HCPCS/CPT codes, and received $441,915 in Medicare payments. The top billing code was 17311 (Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks). Part D data shows 239 prescription claims across 139 beneficiaries totaling $5,846 in drug costs, led by Fluorouracil (Fluorouracil). Open Payments data shows 12 records totaling $315. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,775 to $441,915. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $6,179 and ending at $5,846. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	19	35	$1,775
2016	218	837	$26,106
2017	339	1,057	$40,835
2018	58	139	$8,995
2019	121	312	$75,538
2020	259	765	$211,802
2021	271	1,081	$263,059
2022	391	3,308	$311,998
2023	314	2,745	$277,971
2024	377	7,384	$441,915

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	55	115	$6,179
2017	120	232	$13,270
2018	139	280	$16,782
2019	69	103	$3,585
2020	83	119	$1,698
2021	107	145	$2,572
2022	121	194	$6,073
2023	75	107	$1,827
2024	139	239	$5,846

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
17311	Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks	217	256	$450
17312	Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks	97	134	$296
11102	Biopsy of related skin growth, first growth	75	85	$60
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	123	173	$56
17000	Destruction of precancer skin growth, 1 growth	99	123	$32

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Fluorouracil	Fluorouracil	25	713	$1,559
Ketoconazole	Ketoconazole	35	1,119	$645
Cefadroxil	Cefadroxil	50	643	$526
Doxycycline Hyclate	Doxycycline Hyclate	11	170	$290
Triamcinolone Acetonide	Triamcinolone Acetonide	20	488	$127

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	12	$315	Regeneron Healthcare Solutions, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Anna-Bianca Stashak, D.O.?

Tedicare shows public-source Medicare data for Anna-Bianca Stashak, D.O. (NPI 1740692326), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Anna-Bianca Stashak, D.O. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Anna-Bianca Stashak, D.O.?

Anna-Bianca Stashak, D.O. is linked to TRICITIES SKIN AND CANCER (billing NPI 1295824415) in the available physician profile data.

Does Anna-Bianca Stashak, D.O. have Open Payments data?

Anna-Bianca Stashak, D.O. has 12 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.